Our immune system is armed with an array of defenses designed to detect and eliminate harmful threats. One of its most powerful defense mechanisms is the complement system-a group of proteins that ...

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

The onset of multiple sclerosis (MS) in older individuals correlates with a higher risk of developing primary progressive MS, faster progression to secondary progressive MS, and increased disability ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

Opdivo plus Yervoy shows efficacy and manageable safety as first-line treatment for unresectable hepatocellular carcinoma in ...

TAK-881 is under clinical development by Takeda Pharmaceutical and currently in Phase III for Primary Immune Deficiency (PID). According to GlobalData, Phase III drugs for Primary Immune Deficiency ...

Phase 2b Clinical Trial Data Enrollment Criteria: Primary Endpoint of 12-month EFS: Interim Analysis of Ongoing Secondary Endpoint ... to trigger a strong immune response against cancer cells ...

3,4 Using the PAMO criteria, the authors analysed outcomes for 1258 patients with primary aldosteronism on targeted treatment (mainly mineralocorticoid receptor antagonists) across 28 centres.

A new study has revealed Coventry's best primary and secondary schools. The report ranks the city's primary and secondary school performance based on their SATS and GCSE performance figures during ...

When these proteins are on the surface of our own cells they do not usually initiate an immune response, as they are determined to be “self” antigens. If the proteins are foreign or “non-self” ...